<sentence id="0">The ITIM-bearing CLECSF6 ( DCIR ) is down-modulated in neutrophils by neutrophil activating agents .</sentence>
<sentence id="1">The recently discovered CLECSF6 protein displays the features of a receptor involved in the down-modulation of leukocyte activation .</sentence>
<sentence id="2">Although CLECSF6 has been the focus of the interest of many researchers lately , a Western blot characterization of the protein is still <scope type="neg" id="0"><cue type="neg" id="0">lacking</cue></scope> .</sentence>
<sentence id="3">This highly reduces our ability to gain full knowledge of the biological relevance of this protein in cell responses .</sentence>
<sentence id="4">We produced two rabbit polyclonal antisera that detected a glycosylated protein at approximately 35kDa in neutrophils .</sentence>
<sentence id="5">Four different CLECSF6 mRNA species have been discovered to date .</sentence>
<sentence id="6">When deglycosylated , the protein displayed the molecular weight expected for the longest CLECSF6 form .</sentence>
<sentence id="7">Neutrophil membrane fractions were strongly enriched in the protein .</sentence>
<sentence id="8">We showed a down-modulation of the expression of this protein in neutrophils treated with granulocyte-macrophage-colony stimulating factor ( GM-CSF ) , tumor necrosis factor ( TNF-alpha ) , lipopolysaccharide ( LPS ) , and interleukin (IL)-4 .</sentence>
<sentence id="9">This work supports the <scope type="spec" id="1"> <cue type="spec" id="1">hypothesis</cue> that CLECSF6 is involved in the control of inflammation in neutrophils</scope> .</sentence>